The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.

Arthritis Res Ther · 2012 · PMC3446469 · PMID 22540992

Europe PMC DOI

hedged sentence

0.0599

closest p · 1.2× alpha

0.0599

boldest claim

The sentences

did not reach statistical significanceP = 0.0599so close (0.05 < p ≤ 0.1)

Comparable results were observed when response status was assessed by the EULAR response criteria in good/intermediate responders versus non-responders, although this association did not reach statistical significance ( P = 0.0599) (Figure 1D and 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.